Additionally, experiments on AD mice, including qRT-PCR, IF, and IHC, have further confirmed the overexpression of AEBP1 and downregulation of CARTPT, NPTX2, COPG2IT1, and AK5 in AD, further strengthening the relevance of these biomarkers. This evidence concerns the gene AEBP1 and Alzheimer disease.